Charleston, WV6 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Charleston, WV

Find 6 actively recruiting myalgic encephalomyelitis clinical trials in Charleston, WV. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
2,583
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Charleston

About Myalgic Encephalomyelitis Clinical Trials in Charleston

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 6 myalgic encephalomyelitis clinical trials recruiting participants in Charleston, WV. These studies are seeking a combined 2,583 participants. Research is being sponsored by Sequenom, Inc., Sound Pharmaceuticals, Incorporated, The University of Texas Health Science Center, Houston and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Charleston — FAQ

Are there myalgic encephalomyelitis clinical trials in Charleston?

Yes, there are 6 myalgic encephalomyelitis clinical trials currently recruiting in Charleston, WV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charleston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.

Are clinical trials in Charleston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 6 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov